Laurene Redding

Laurene Redding is a knowledgeable pharmaceutical executive with a diverse range of experiences and expertise within the industry. Her skill set encompasses various aspects of commercial access in Canada, including health economics, pricing, contracting, tendering, corporate communications, government relations, strategic planning, patient support programs, and market access. She possesses a spirit of curiosity for experimentation coupled with the determination to execute and persevere.

With a background that includes working in a start-up as a single incumbent to leading large high-performing teams in small, mid-sized, and large biopharmaceutical companies, Laurene has been acknowledged for exceptional individual and team performance. She has a track record of successfully launching products across different therapeutic areas such as primary care, specialty, rare diseases, and oncology.

Laurene Redding's educational background includes an MBA with a focus on Health Services Management Co-op and an Honours Bachelor of Science in Biology & Pharmacology Co-op, both from McMaster University.

Throughout her career, Laurene has held key positions in reputable organizations, such as Head of Value, Access & Policy (Canada) at BeiGene, Vice President at TACT, AVP of Pharmaceutical Benefits & Innovation at Sun Life, Director of Pricing, Contracting & Negotiations at AstraZeneca, Vice President of Market Access & External Affairs at Takeda Canada Inc., Director of Market Access & External Affairs at Novo Nordisk Canada Inc., Director of Health Economics & Pricing at Hoffmann-La Roche Canada, Health Economics Manager at Hoffmann-La Roche Canada, Market Access Associate at Sanofi-Sythelab, and Senior Research Associate at INNOVUS Research.